Primary Site >> Liver Cancer
Gene >> NAT2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Arylamine N-acetyltransferase activity in human cultured cell lines. PMID: 8396914 |
Ref: Interaction between dose and susceptibility to environmental cancer: a short review. PMID: 9255556 |
Ref: Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. PMID: 10026993 |
Ref: Induction of cytochrome P450 1A1 in human hepatoma HepG2 cells by 6-nitrochrysene. PMID: 11033235 Ref: Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. PMID: 11034589 |
Ref: Hepatocellular carcinoma: susceptibility markers. PMID: 11220663 |
Ref: N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease. PMID: 11858170 Ref: Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation. PMID: 11911601 Ref: [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism]. PMID: 12611196 |
Ref: Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. PMID: 12818290 Ref: Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine. PMID: 12877350 Ref: Antituberculosis drug-induced hepatitis: risk factors, prevention and management. PMID: 15332488 |
Ref: N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study. PMID: 15688397 Ref: Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China? PMID: 15770721 |
Ref: Comparison of biomarkers in workers exposed to 2,4,6-trinitrotoluene. PMID: 17438651 |
Ref: Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. PMID: 19643819 Ref: Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline. PMID: 19666988 |
Ref: Joint effect of polymorphism in the N-acetyltransferase 2 gene and smoking on hepatocellular carcinoma. PMID: 22293947 Ref: Influence of arylamine N-acetyltransferase, sex, and age on 4-aminobiphenyl-induced in vivo mutant frequencies and spectra in mouse liver. PMID: 22508569 Ref: Genetic polymorphism of drug metabolizing enzymes in association with risk of bile duct cancer. PMID: 23480767 |
Ref: Large-scale proteome quantification of hepatocellular carcinoma tissues by a three-dimensional liquid chromatography strategy integrated with sample preparation. PMID: 24972180 |
Ref: Relative Contributions of CYP1A2 and CYP2E1 to the Bioactivation and Clearance of 4-Aminobiphenyl in Adult Mice. PMID: 25922528 |
Ref: A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma. PMID: 27563447 |
Ref: Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). PMID: 28817838 |
Ref: The Interaction of Smoking with Gene Polymorphisms on Four Digestive Cancers: A Systematic Review and Meta-Analysis. PMID: 29721061 Ref: Screening therapeutic targets of ribavirin in hepatocellular carcinoma. PMID: 29805683 |